Graphene quantum dots show promise in targeting Parkinson's-related protein clumping

Graphene quantum dots show promise in targeting Parkinson's-related protein clumping

The buildup of a protein called 𝛂-synuclein (ASN) into toxic clumps is a hallmark of synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's and multiple system atrophy (MSA). These aggregates are associated with cellular dysfunction and lead to progressive neuronal loss. Because current treatments only manage symptoms rather than stopping the underlying protein clumping, scientists are exploring new strategies, inclu…

What do graphene quantum dots do in Parkinson’s?

Graphene quantum dots target alpha synuclein clumping Scientists have demonstrated that specially engineered graphene quantum dots can be used to target and inhibit the clumping of a key brain protein linked to Parkinson’s disease. The protein, alpha synuclein (often abbreviated ASN), forms toxic…

Scientists have successfully demonstrated that specially engineered graphene quantum dots can effectively target and inhibit the dangerous clumping of specific brain proteins that are fundamentally linked to the onset and progression of Parkinson's diseas